Canopus BioPharma Incorporated

Canopus BioPharma, Inc. is dedicated to providing the safest, most cost effective and efficacious pharmaceutical products and assay methods in the areas of infectious disease, radiation protection, cancer, and addiction. With innovative science, proven research and development leadership, and superior products and compounds, Canopus BioPharma has, since 2001, been committed to becoming a market trend setter in a new era of healthcare. Canopus maintains staff in Australia, South Africa, Ireland and the USA. Additional information on the Company is available at http://www.canopusbiopharma.com.